Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Yakugaku Zasshi ; 136(5): 769-76, 2016.
Article in Japanese | MEDLINE | ID: mdl-27150933

ABSTRACT

Falls are common in elderly patients and are often serious. Several drugs have been associated with an increased risk of fall. Older adults often take multiple drugs for chronic diseases, and thus may be at increased risk from drugs associated with fall. We investigated the association between drug use and falling in hospitalized older people, with the goal of identifying medications that may increase the risk of a fall. A retrospective case control study was performed at the National Hospital Organization Kumamoto Saishunso Hospital in Japan. Medications taken by patients who fell (n=57) were compared with those taken by patients who did not fall (n=63). The median age (interquartile range; IQR) of the fall and non-fall groups were 75.0 (67.0-83.0) and 80.0 (70.3-84.5) years, respectively. The characteristics of the two groups were similar, with no significant differences in age, sex, or body weight. The probability of falling increased when the patients used zolpidem [odds ratio (OR)=2.47; 95%CI: 1.09-5.63; p<0.05] and calcium channel antagonists (OR=0.299; 95%CI: 0.13-0.68; p<0.01), and was also related to physical factors (OR=2.27; 95%CI: 1.01-5.09; p<0.05). Elderly patients taking zolpidem may fall due to sleepiness, and blood pressure control may be important to prevent orthostatic high blood pressure. In the treatment of elderly people, medical staff should try to choose drugs that prevent fall or are not associated with falling.


Subject(s)
Accidental Falls/prevention & control , Accidental Falls/statistics & numerical data , Calcium Channel Blockers/adverse effects , Hypnotics and Sedatives/adverse effects , Inpatients , Pyridines/adverse effects , Aged , Aged, 80 and over , Calcium Channel Blockers/administration & dosage , Case-Control Studies , Female , Humans , Hypnotics and Sedatives/administration & dosage , Logistic Models , Male , Pyridines/administration & dosage , Retrospective Studies , Risk , Zolpidem
2.
J Infect Chemother ; 22(5): 314-8, 2016 May.
Article in English | MEDLINE | ID: mdl-26923258

ABSTRACT

We compared the predictive accuracy of TEIC concentrations (TEIC_conc) calculated using either serum cystatin C (CysC) or serum creatinine (SCr) and the population mean method using the mean population parameter of TEIC_conc for Japan. We also compared the predicted TEIC_conc to measured TEIC_conc. Creatinine clearance (CLCr) predicted using the Cockcroft-Gault (C&G) equation with SCr was 45.23 mL/min (interquartile range [IQR]: 32.12-58.28), and the glomerular filtration rate (GFR) predicted using the Hoek equation with CysC was 45.23 mL/min (IQR: 35.40-53.79). The root mean-squared prediction error (IQR) based on CLCr predicted using the C&G equation with SCr was 6.88 (3.80-9.96) µg/mL, and that based on GFR predicted using the Hoek equation with CysC was 6.72 (3.77-9.68) µg/mL. Predicted TEIC_conc did not differ significantly between the two methods. The predictive accuracy of the TEIC_conc using the Hoek equation with CysC was similar to that of CLCr using the C&G equation with SCr. These findings suggest that the predictive accuracy of the TEIC_conc using CLCr based on the G&G equation and SCr might be sufficient for the initial dose adjustment of TEIC. Given that we were unable to confirm that CysC is the optimal method for predicting TEIC_conc, the expensive measurement of CysC might not be necessary.


Subject(s)
Anti-Bacterial Agents/blood , Creatinine/blood , Cystatin C/blood , Glomerular Filtration Rate/physiology , Models, Statistical , Teicoplanin/blood , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/therapeutic use , Female , Gram-Positive Bacterial Infections/drug therapy , Humans , Male , Retrospective Studies , Teicoplanin/pharmacokinetics , Teicoplanin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...